PROGRAM

FEBRUARY 13TH 2020, THURSDAY
13:00 – 13:30 OPENING CEREMONY  
     
13:30 – 14:30 IMMUNOLOGY AND IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS
Chairs: Egemen İdiman, Ceyla İrkeç
  T & B Cells in Multiple Sclerosis Güher Saruhan Direskeneli
  Neuroinflammation in the Immunopathogenesis of Multiple Sclerosis Egemen İdiman
  Neurodegeneration in the Immunopathogenesis of Multiple Sclerosis Canan Yücesan
14:30 – 15:00 Coffee Break  
15:00 – 16:00 GENETIC AND ENVIRONMENTAL RISK FACTORS IN MULTIPLE SCLEROSIS
Chairs: Ufuk Aluçlu, Orhan Adalı
  The Role and Effect of Modifiable Environmental Factors in Multiple Sclerosis Serhan Sevim
  The Role of Vitamin D in Multiple Sclerosis Emre Evin
  Inflammasome and Epigenetics in Multiple Sclerosis Ceyla İrkeç
16:00 – 16:15 Coffee Break  
16:15 – 17:15 CLINIC AND DIAGNOSIS OF MULTIPLE SCLEROSIS
Chairs: Mefkure Eraksoy, Aslı Tuncer
  Clinical Presentation of Multiple Sclerosis with Case Samples, Typical and Atypical Features in Clinic Belgin Koçer
  Clinical Features in Pediatric Multiple Sclerosis Ayten Mamedbeyli
  McDonald-2017 Criteria and MS Diagnosis Today Hüsnü Efendi
17:15 – 17:30 Coffee Break  
17:30 – 18:30 LABORATORY IN MULTIPLE SCLEROSIS
Chairs: Hüsnü Efendi, Kunduz Karbazova
  The Role of MRI in Diagnosis of Multiple Sclerosis and Pitfalls Mefkure Eraksoy
  Current Status of CSF and Neurofilament Light Chain in Multiple Sclerosis Murat Terzi
  OCT – OCTA in Multiple Sclerosis Fethi İdiman
 
FEBRUARY 14TH 2020, FRIDAY
09:00 – 10:00 STEM CELLS, MICROBIOTA AND BIOMARKERS IN MULTIPLE SCLEROSIS
Chairs: Faruk Turan, Birsen Can Demirdöğen
  Brain Intestinal Axis Semir Beyaz
  Stem Cell Based Molecular Mechanism Studies in MS Erkan Kiriş
  Biomarkers in CSF and Blood Ufuk Ergün
10:00 – 10:15 Coffee Break  
10:15 – 12:00 CURRENT TREATMENT OPTIONS IN MULTIPLE SCLEROSIS
Chairs: Serpil Demirci, Maira Abdrakhmanova
  Treatment of Attacks Semra Mungan
  The Role of Plasmapheresis in the Treatment of Multiple Sclerosis Rakhimbaeva Gulnara Sattarovna
  INF-GA Haluk Gümüş
  Oral Treatments Sibel Güler
  Monoclonal Antibodies Faruk Turan
12:00 – 13:30 Lunch  
13:30 – 14:30 TREATMENT AND TREATMENT MAP IN SPECIAL CONDITIONS – 1
Chairs: Yusuf Tamam, Sholpan Kaliyeva
  Roadmap for Treatment Selection and Replacement Sibel Canbaz Kabay
  Effect of Comorbid Conditions on Treatment Choice Münire Kılınç Toprak
  Pseudo-Progression of Multiple Sclerosis Cavit Boz
14:30 – 15:30 SATELLITE SYMPOSIUM (Gen İlaç)
  
15:30 – 16:00 Coffee Break  
16:00 – 17:00 TREATMENT AND TREATMENT MAP IN SPECIAL CONDITIONS – 2
Chairs: Abdurrahman Neyal, Manija Ganieva
  Treatment of Multiple Sclerosis During Pregnancy Planning and Pregnancy Aylin Akçalı
  Pharmacogenomics in Treatment of Multiple Sclerosis and Individualization in Treatment Rena Şiraliyeva
  Risk Management in Multiple Sclerosis & Tests for Starting New Treatments and Interpretations Özlem Taşkapılıoğlu
 
FEBRUARY 15TH 2020, SATURDAY
09:00 – 10:00 SYMPTOMATIC TREATMENT IN MULTIPLE SCLEROSIS
Chairs: Funda Uysal Tan, Djamal Turgunbayev
  Cognitive Disorders and Treatment in Multiple Sclerosis S.T. Turuspekova
  Sleep Disorders and Treatment in Multiple Sclerosis Semai Bek
  Treating Spasticity and Tremor Gençer Genç
10:00 – 10:30 Coffee Break  
10:30 – 11:30 NEUROMYELITIS OPTICA (NMO)
Chairs: Ayşe Altıntaş, Rena Şiraliyeva
  Neuromyelitis Optica Spectrum Disorders Münife Neyal
  Primary and Secondary Inflammatory Diseases Mimicking Multiple Sclerosis Levent Sinan Bir
  NMOSD Treatment Today & In the Future Egemen İdiman
11:30 – 12:15 CONTROVERSIAL ISSUES 1 –  ANTI-MOG ANTIBODY RELATED CENTRAL NERVOUS SYSTEM DEMYELINATION, NMOSG ? MS ? OR NEW DISEASE ?
Chairs: Cemal Özcan, Murat Terzi
  Debaters: Sedat Şen, Cihat Uzunköprü, Mehmet Fatih Yetkin, Demet Yandım Kuşcu  
12:15 – 14:00 Lunch  
14:00 – 15:30 MULTIPLE SCLEROSIS PHENOTYPE AND PREVALANCE BY COUNTRIES – 1
Chairs: Şeref Demirkaya, Furkat Yusupov
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Uzbekistan Madzhidova Yokutkhon Nabievna
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Samarkand Territory Jurabekova Aziza Tahirovna
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Kirghizistan Kunduz Karbozova
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Tajikistan Manija Ganieva
15:30 – 16:00 Coffee Break  
16:00 – 17:30 MULTIPLE SCLEROSIS PHENOTYPE AND PREVALANCE BY COUNTRIES – 2
Chairs: Ufuk Ergün, Markhamat Yakubova
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Kazakhistan E.S. Nurguzhayev
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Azerbaijan Rena Siyeleva
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Turkish Republic Of Northern Cyprus Sıla Usar
  Characteristics, Diagnosis and Treatment Opportunities of Multiple Sclerosis in Turkey Erdem Toğrul
 
FEBRUARY 16TH 2020, SUNDAY
09:00 – 09:45 CONTROVERSIAL ISSUES 2–  CAN TREATMENT BE TERMINATED IN MS? WHEN? WHICH CASE?
Chairs: Alev Leventoğlu, Dilcan Kotan
  Debaters: Caner Feyzi Demir, Tuncay Gündüz, Şeyda Figül Gökçe, Belgin Petek Balcı  
09:45 – 11:15 ORAL PRESENTATION SESSION 1
Chairs: Alaattin Şen, Belgin Koçer, Jurabekova Aziza Tahirovna
11:15 – 11:30 Coffee Break  
11:30 – 13:00 ORAL PRESENTATION SESSION 2
Chairs: Berna Arlı, Cavit Boz, Rakhimbaeva Gulnara Sattarovna
13:00 – 13:30 RATIONAL DRUG SESSION
Chairs: Erdem Toğrul, Aynur Feyzioğlu 
  Speaker: Tahir Kurtuluş Yoldaş